There have been 17 recent insider transactions recorded for NovaBridge Biosciences (NBP), including 0 buys and 0 sells.
Notable insiders with recent activity include Au Chun Kwok Alan, Cunningham Emmett, Fu Wei. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — NBP
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-18 |
Au Chun Kwok Alan |
Director |
Unknown |
34,530 |
$3.86 |
$133.29K |
- |
| 2026-03-18 |
Cunningham Emmett |
Director |
Unknown |
120,000 |
$3.21 |
$385.2K |
- |
| 2026-03-18 |
Fu Wei |
Director |
Unknown |
2,453,583 |
$3.19 |
$7.83M |
- |
| 2026-03-18 |
Lenz Robert A. |
Director |
Unknown |
22,460 |
- |
- |
- |
| 2026-03-18 |
Fu Xi-yong |
See Remarks |
Unknown |
1,245,000 |
$1.07 |
$1.33M |
- |
| 2026-03-18 |
Lei Ming Kyler |
Chief Financial Officer |
Unknown |
996,775 |
$4.25 |
$4.24M |
- |
| 2026-03-18 |
Cao Sean Wuxiong |
See Remarks |
Unknown |
408,929 |
$4.65 |
$1.9M |
- |
| 2026-03-18 |
Zhang Adeline Yi |
Officer |
Unknown |
- |
- |
- |
- |
| 2026-03-18 |
Wu Joanna Xuqiong |
See Remarks |
Unknown |
24,169 |
- |
- |
- |
| 2026-03-18 |
Lin Liwei Lorraine |
Officer |
Unknown |
- |
- |
- |
- |
| 2026-03-18 |
Xu Cong Claire |
See Remarks |
Unknown |
5,405 |
- |
- |
- |
| 2026-03-18 |
Woo Ian Ying |
Director |
Unknown |
17,310 |
- |
- |
- |
| 2026-03-18 |
Liu Xin |
Officer |
Unknown |
- |
- |
- |
- |
| 2026-03-18 |
Zhang Xiaofan Neo |
Chief Investment Officer |
Unknown |
- |
- |
- |
874,000 |
| 2026-03-18 |
Dennis Phillip Andrew |
Chief Medical Officer |
Unknown |
92,724 |
- |
- |
- |
| 2026-03-18 |
Chu Denny Hsueh Wen |
Officer |
Unknown |
- |
- |
- |
- |
| 2026-03-18 |
Yang Conor Chia-hung |
Director |
Unknown |
34,530 |
$3.86 |
$133.29K |
- |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
